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Protein scaffolds that support molecular recognition have
multiple applications in biotechnology. Thus, protein
frames with robust structural cores but adaptable surface
loops are in continued demand. Recently, notable pro-
gress has been made in the characterization of Ig
domains of intracellular origin—in particular, modular
components of the titin myofilament. These Ig belong to
the I(intermediate)-type, are remarkably stable, highly
soluble and undemanding to produce in the cytoplasm of
Escherichia coli. Using the Z1 domain from titin as repre-
sentative, we show that the I-Ig fold tolerates the drastic
diversification of its CD loop, constituting an effective
peptide display system. We examine the stability of CD-
loop-grafted Z1-peptide chimeras using differential
scanning fluorimetry, Fourier transform infrared spec-
troscopy and nuclear magnetic resonance and demon-
strate that the introduction of bioreactive affinity binders
in this position does not compromise the structural integ-
rity of the domain. Further, the binding efficiency of the
exogenous peptide sequences in Z1 is analyzed using pull-
down assays and isothermal titration calorimetry. We
show that an internally grafted, affinity FLAG tag is
functional within the context of the fold, interacting with
the anti-FLAG M2 antibody in solution and in affinity
gel. Together, these data reveal the potential of the intra-
cellular Ig scaffold for targeted functionalization.
Keywords: differential scanning fluorimetry/infrared
spectroscopy/intracellular Ig domain/NMR spectroscopy/
protein scaffold engineering for peptide display
Introduction
Protein scaffolds with adaptable molecular recognition prop-
erties are widely used in biotechnology and biomedicine, e.g.
in medical imaging, immunoassays, microarrays and intracel-
lular therapy. Many applications rely on antibodies, antibody
fragments or their engineered variants (e.g. Fab, single-chain
variable fragments (scFv), diabodies, triabodies and
minibodies) that have been used as archetypal binders for
decades (Holliger and Hudson, 2005; Lo et al., 2008; Wurch
et al., 2008; Nelson and Reichert, 2009). Antibodies are
naturally produced by the immune system through a process
of hypermutation that yields myriads of variants with unique
binding attributes. This versatility relies on the structural
plasticity of the Ig fold of antibody domain components. The
Ig fold (10 kDa) consists of two amphipathic b-sheets that
pack against each other to form a b-sandwich. Several fold
variants are found in proteins that differ in b-strand compos-
ition and loop architecture, forming the Ig-like superfamily
(Halaby et al., 1999). Among these, the V(variable)-Ig type
mediates antigen recognition in antibodies. This Ig has three
hypervariable loops (BC, C0C00, FG) at the N-terminal pole
of the b-sandwich, which can accommodate large differences
in sequence, length and conformation, being efficient display
loci for binder motifs. Thus, the V-Ig fold is regarded as the
canonical protein scaffold.
Antibodies can be developed through immunization or
in vitro display methods to exhibit high binding affinity and
specificity. However, their complex architecture (requiring
glycosylation and disulfide bond formation) makes them
costly to manufacture, needing stably transfected mammalian
cell lines (Steinmeyer and McCormick, 2008). Antibody frag-
ments and their engineered variants, that have simplified
structures and can be optimized through design, are more
amenable to economical bacterial expression. These smaller
binders also have functional advantages, being able to access
cryptic epitopes and allowing the production of immunocon-
jugates by fusion to molecules such as enzymes for pro-drug
therapy, toxins for cancer treatment and liposomes for drug
delivery (Holliger and Hudson, 2005; Nelson and Reichert,
2009). Fragments, however, often suffer aggregation due to
the hydrophobicity of their surface. This problem can be alle-
viated by surface mutagenesis but success is variable
(Nelson and Reichert, 2009). Interest in small Ig binders was
boosted by the discovery that camelids and cartilaginous fish
have high-affinity single V-Ig that can be produced as
soluble and stable in vitro products, and whose humanization
makes them promising for clinical applications (Nelson and
Reichert, 2009).
Difficulties with the production and intellectual property
context of Ig-based binders triggered a search for alternative
protein scaffolds. Non-Ig frames are now available that can
be re-engineered through combinatorial protein design and in
vitro selection to exhibit tailored binding functions (Wurch
et al., 2008; Gebauer and Skerra, 2009; Gro¨nwall and Sta˚hl,
2009; Lo¨fblom et al., 2011). Examples of new scaffolds are:
affibodies derived from protein A, lipocalin-based anticalins,
designed ankyrin repeat domains, knottins and adnectins.
The latter, derived from the 10th domain of fibronectin, have
a Fn3 fold that also belongs to the Ig-like superfamily, being
the only member with scaffold properties other than the
V-Ig. The advantages of these new frames are (i) their low
manufacturing cost; (ii) the ease of generating multispecific
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molecules; and (iii) their strong activity in in vitro models.
These proteins replace and even surpass antibody perform-
ance in applications such as medical imaging and diagnostic
protein microarrays, and several have progressed to clinical
testing showing promise as biotherapeutics (Wurch et al.,
2008; Gro¨nwall and Sta˚hl, 2009; Lo¨fblom et al., 2011). Thus,
the relevance of alternative scaffolds is expected to continue
increasing.
Intracellular variants of the Ig fold that belong to the
I(intermediate)-type (Halaby et al., 1999) are found as
modular components of muscle filaments and cytoskeletal
proteins, where they occur in high number (Kontrogianni-
Konstantopoulos et al., 2009). A prominent example of an
intracellular poly-Ig protein is the titin myofilament that con-
tains .300 Ig and Fn3 domains linked in tandem (Labeit
and Kolmerer, 1995). Titin domains offer ease of production
in bacterial systems, and are highly soluble and highly stable.
In recent years, significant knowledge of their atomic struc-
ture has been gained, with 3D models now available for 17
Ig and 4 Fn3 modules from titin. Namely (from N- to
C-terminus of titin), Ig domains Z1 and Z2 (Marino et al.,
2006; Zou et al., 2006), I1 (Mayans et al., 2001), I65–I70
(von Castelmur et al., 2008), I91 (previously I27) (Improta
et al., 1996), A164 and A165 (PDB entry 3LCY), A168 and
A169 (Mrosek et al., 2007; Mu¨ller et al., 2007), M1 (2BK8),
M5 (Pfuhl and Pastore, 1995) and M10 (Pernigo et al.,
2010); and Fn3 domains A71 (Goll et al., 1998), A77 and
A78 (Bucher et al., 2010) and A170 (Mrosek et al., 2007).
These folds are not stabilized by disulfide bonds but by
robust hydrophobic cores that confer them stability in the
intracellular environment. Supporting the expectation that
these domains might be of technological interest, Z1–Z2
have been recently employed in the engineering of self-
assembling protein nanofibers (Bruning et al., 2010) and the
tandem I65–I70 has been shown to form layers on liposomes
(Chami et al., 2011). In contrast, obtaining higher order
assemblies using antibodies requires polymeric environ-
ments: e.g. the entrapment of antibody-coated beads in
hydrogels for the generation of protein microarrays (Charles
et al., 2004). These approaches allow little control over the
distribution of functions in a material. In this regard, the I-Ig
type might offer the ease of introducing molecular recogni-
tion into self-organizing systems. Further, intracellular
binders that track or block endogenous proteins are valuable
tools for the manipulation of cellular processes. For example,
redesigned scFv intrabodies are applied in cancer, auto-
immune and neurodegenerative disease and transplantation
(Lo et al., 2008), as well as in cellular imaging (Gro¨nwall
and Sta˚hl, 2009). However, the development of intrabodies is
troubled by the difficulty of imposing an in vitro selection
pressure for intracellular stability (Lo et al., 2008). The intra-
cellular Ig frame might be valuable in this context.
Yet, most Ig from titin play structural roles and those few
known to mediate protein interactions do not utilize V-Ig
equivalent loops. For example, Z1–Z2 and M10 interact
with their respective protein partners, telethonine and
obscurin-like-1, by forming an inter-molecular b-sheet
through their b-strand G (Zou et al., 2006; Pernigo et al.,
2010); and domain A169 binds MuRF1 through a unique
loop in the A–A0 region (Mrosek et al., 2007). In fact, the
N-terminal, hypervariable loops of V-Ig are short and con-
served in the I-Ig type of titin (Marino et al., 2005), so that
their modification might be poorly tolerated. Accordingly, a
study that modified I91 (ex I27) by introducing five glycine
residues in the BC loop showed that this did not affect the
overall fold, but caused a large destabilization (Wright et al.,
2004). Thus, it is unclear whether this Ig type can mediate
interactions through its loop regions. Using the well-
characterised Z1 domain as representative, we have explored
the potential of the intracellular Ig type to act as an adaptable
scaffold in mediating protein interactions.
Materials and methods
Sequence conservation
The 3D structures of titin domains Z1 and Z2 (PDB entry
2A38), I1 (1G1C), I65–I70 (3B43), A164 (3LCY), A168
(2NZI), M1 (2BK8) and M10 (2Y9R) were aligned using
PDBeFOLD (Krissinel and Henrick, 2004) that matched their
secondary structure (root mean square deviation ,1.5 A˚ for
all models). Next, the sequences of all other Ig from titin (as
defined in entry Q8WZ42, UniProtKB) were aligned against
the structure-based alignment using PROMALS3D (Pei
et al., 2008). Conservation percentages were calculated in
PROTSKIN (Deprez et al., 2005) with the BLOSUM62
matrix and mapped onto the Z1 structure using 10 color
levels corresponding to 10% conservation increments.
Cloning
Cloning of titin Z1 (residues 1-99; Q8WZ42) was in the
pETM-11 vector (EMBL plasmid collection) using KpnI and
NcoI restriction sites. This vector incorporates a His6-tag and
a tobacco etch virus (TEV) protease cleavage site N-terminal
to the target construct. Z1 variants were constructed from the
wild-type clone using overlap extension PCR, where
sequences were introduced in Z1 between residues D42 and
L51. For this, first, two DNA fragments were constructed
coding for Z1 residues 1–42 and 51–99 and containing
additional codons for the inserted sequences at the respective
30 or 50 termini. Then, the overlap in the added sequences of
the resulting DNA fragments generated the entire Z1 variant
construct. All clones were confirmed by sequencing.
The expression clone of the SH3 domain from Pexp13 has
been previously reported (Douangamath et al., 2002).
Protein production
Recombinant overexpression of Z1 and its variants was
carried out in Escherichia coli Rosetta (Novagen) using a
same protocol. Cells were grown in Luria–Bertani medium
supplemented with 25 mg/ml kanamycin and 34 mg/ml chlor-
amphenicol at 378C up to an OD600 of 0.6–0.8.
Protein expression was induced with 1 mM isopropyl
b-D-thiogalactoside and cultures grown further at 208C over-
night for a minimum of 12 h. Harvesting of the cells was by
centrifugation. For purification, cell pellets were resuspended
in a lysis buffer containing 50 mM Tris-HCl pH 7.4,
100 mM NaCl and supplemented with 1 mg/ml lysozyme,
0.01 mg/ml Dnase I. Cells were lysed by sonication. Lysates
were clarified by centrifugation and supernatants were
applied to a Ni2þ-nitrilotriacetate Hi-Trap column (GE
Healthcare) equilibrated in lysis buffer. Elution used
200 mM imidazole. Eluted fractions were dialyzed against
lysis buffer in the presence of TEV protease and 1 mM
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dithiothreitol for His6-tag removal. Further purification was
by substractive metal affinity and size-exclusion chromatog-
raphy in a Superdex 75 HR16/60 column (GE Healthcare)
equilibrated in lysis buffer. Purified samples were concen-
trated to 1 mM and stored at 48C until further use.
Differential scanning fluorimetry
The thermal denaturation of Z1 and its variants was recorded
by differential scanning fluorimetry (DSF) in triplicate on a
7500 Fast Real Time PCR System (Applied Biosystems) in
the presence of Sypro Orange (Invitrogen) using a wave-
length of 560 and 582 nm for fluorescence excitation and
detection, respectively (Niesen et al., 2007). The concentra-
tion of all protein samples was 50 mM in a final sample
volume of 10 ml in Tris-HCl pH 7.4, 100 mM NaCl. A Sypro
Orange 100 solution was added at 10% (v/v) in a Fast
Optical 96 Well Reaction Plate (Applied Biosystems). The
heating cycle comprised a 120-s prewarming step at 318C
and a subsequent gradient 32–818C obtained in 99 steps of
20 s (0.58C ramp). Human acidic fibroblast growth factor
was used as a control, showing a Tm ¼ 488C in good agree-
ment with previously reported values (Chi et al., 2001). Data
were corrected for background fluorescence at time t ¼ 0 and
normalized using GNUPLOT (www.gnuplot.info). Tm values
and standard deviations were obtained from the first deriva-
tive of the triple DSF runs.
Fourier transform infrared spectroscopy
Prior to the measurements, buffers were prepared in 100%
D2O to consist of 100 mM deuterated phosphate buffer pD
7.6, 100 mM NaCl. Sample media were exchanged thor-
oughly against these buffers by sequential dialysis over a
16-h period. Protein concentrations were: Z1 13.6 mg/ml,
Z1PxxP 13.7 mg/ml, Z1FLAG 7.8 mg/ml. Fourier transform
infrared (FTIR) spectra were recorded at 108C on a Bio-Rad
FTS-40 FTIR spectrometer equipped with a liquid nitrogen-
cooled HgCdTe detector using a temperature-controlled
IR-cell with CaF2 windows and 50 mm spacer. For each
spectrum, 500 scans with 1 cm21 resolution were averaged.
All spectra were corrected to yield a flat spectrum in the
region 2000–1800 cm21 by subtracting an appropriately
scaled buffer spectrum.
Nuclear magnetic resonance spectroscopy
Uniform labeling with 15N (Z1FLAG) or 15N and 13C (Z1)
was carried out by recombinant expression in M9 medium
supplemented with 1 g/l 15NH4Cl and/or 2 g/l [
13C6]-glucose
as nitrogen and carbon source, respectively. Production pro-
tocols were otherwise as those of unlabeled samples.
Samples were concentrated to 1 mM in 20 mM phosphate
buffer pH 6.0, 20 mM NaCl, 5% (v/v) D2O. Nuclear
magnetic resonance (NMR) measurements were carried out
at 258C on a Bruker ADVANCE DRX 600 equipped with a
CryoProbe. Referencing of the proton chemical shifts was to
external DSS, while the 15N and 13C chemical shifts were
indirectly referenced using recommended gyromagnetic
ratios (Wishart et al., 1995). All spectra were processed and
analysed using the software TopSpin (Bruker) and CCPN
(Vranken et al., 2005), respectively. For the sequential
assignment of backbone NH, N, CO, Ca and Cb resonances
the following experiments were recorded for wild-type Z1
and Z1FLAG: 3D HNCO, 3D HNCACB, 3D CACB(CO)NH.
Initial values for the chemical shifts were obtained from the
Z1–Z2 tandem (BioMagResBank, entry 5760; Edlich and
Muhle-Goll, 2003), and adjusted for Z1. Due to the large dif-
ferences between the [1H,15N]-HSQC of Z1 and Z1FLAG, the
resonances of Z1FLAG were assigned independently using the
3D spectra. The degree of broadening in the [1H,15N]-HSQC
spectrum of Z1FLAG was estimated from the ratio IZ1FLAG/IZ1
of the cross-peak intensities. The ratio was normalized to
give an average value of 1 for the non-broadened resonances.
The difference between the average backbone 13C chemical
shift values of Z1 and Z1FLAG was calculated as (DCO2þ
DCa2þ DCb2)21/2/3. The dihedral angles for both samples
were predicted from the chemical shift values using the
DANGLE (Cheung et al., 2010) module in CCPN (Vranken
et al., 2005). Backbone 13C, 15N and 1Ha chemical shifts
were used in the dihedral angle prediction.
Anti-FLAG binding assay
The binding of the FLAG peptide in Z1FLAG was tested by
pull-down using anti-FLAG M2 affinity gel (Sigma).
Wild-type Z1 was employed as negative control. Both Z1
and Z1FLAG were used at a concentration of 0.1 mM in
50 mM Tris-HCl pH 7.4, 100 mM NaCl. In independent
experiments, each sample was applied to 200 ml of
anti-FLAG resin. The resin was then washed four times with
sample buffer and bound protein eluted with 1 mM FLAG
peptide (Sigma). All fractions were monitored by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE).
Isothermal titration calorimetry
Samples were thoroughly dialyzed against 50 mM Tris-HCl
pH 7.4, 100 mM NaCl, 0.05% NaN3 and data then recorded
with an iTC200 calorimeter (Microcal) at 258C. Titrations
consisted of 2 ml injections of Z1FLAG concentrated to
0.1 mM into anti-FLAG M2 antibody (SIGMA F1804) solu-
tions at 0.01 mM. The time interval between injections was
200–300 s. The data were corrected for the heat of dilution
by subtracting the small constant heat obtained at the end of
the titration, where no further binding occurs.
Results and discussion
Fold conservation in intracellular Ig domains from titin
To reveal regions of natural variability in the I-Ig fold of
titin, we studied the sequence conservation of its Ig modules
(Supplementary Fig. S1) and mapped conservation levels
onto the 3D structure of Z1 (Fig. 1). This exposed two main
areas of fold preservation: (i) the hydrophobic core and (ii)
loops BC and FG in the N-terminal apex of the fold. The
hydrophobic core primarily consists of an almost strictly con-
served tryptophan residue, W39 in b-strand C, and residues
L65 and Y78 in b-strands E and F, respectively, which are
89 and 93% conserved. Residue W39 belongs to the signa-
ture motif of canonical Ig domains (Ioerger et al., 1999),
while Y78 forms the classical ‘tyrosine corner’ (Hamill
et al., 2000). Both residues are highly conserved across the
Ig superfamily and are important for folding and stability
(Halaby et al., 1999). The conservation in the N-terminal
loop region (hypervariable in V-Ig domains) involves a Pro
residue from the BC loop (P33) and an NxxG motif in the
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FG b-hairpin. These residues define the packing of the
N-terminal loop cluster and their structural role in the I-Ig
fold has been previously described (Marino et al., 2005).
The most variable parts in these Ig are loops CD and EF,
at the C-terminal pole of the b-sandwich, which are con-
served in length but vary in sequence. While the EF loop
packs against the A0B connector, the CD loop (residues 43–
53 in Z1) protrudes from the b-sandwich and is highly
exposed (Fig. 1a). The CD loop is orthogonal to the longitu-
dinal axis of the fold, being also accessible within the
context of the natural poly-Ig arrays of titin. Only one
position in this loop is conserved, residue I46, which is
always hydrophobic and in 91% of the modules is the
isomeric rest Ile/Leu. This position is spatially close to the
core residues W39 and Y78 (Fig. 1c), and contributes to
the packing of the CD loop against the b-sandwich, suggest-
ing that it might be important for fold stability. However,
overall, the variability and accessibility of the CD loop indi-
cates that this is a good candidate for engineering purposes.
Viable Z1 variants obtained by loop grafting
To explore the potential of the CD loop to display exogenous
peptide sequences, we grafted two established recognition
motifs on the corresponding region of Z1. Two variants,
Z1FLAG and Z1PxxP, were constructed (Fig. 1b). In Z1FLAG,
eight naturally occurring residues were replaced by the
FLAG sequence (DYKDDDDK), which is a conventional
affinity tag. In Z1PxxP, 9 native residues were substituted for
a 14 amino acid (aa) sequence (EAMPPTLPHRDWKD) con-
taining a canonical PxxP motif for SH3 domain recognition.
The sequence used here is a segment from the peroxisomal
protein Pex14p that interacts tightly with the SH3 domain
from Pex13p (Douangamath et al., 2002). The selection of
peptides in this study was directed to probe two contrasting
scenarios regarding loop composition and conformation. In
FLAG, the sequence is highly charged and it is expected to
form an unstructured, flexible loop within Z1. On the
contrary, the PxxP peptide has a high hydrophobic content
and stringent binding requirements, where the recognition
sequence spans eight aa that must form an extended arrange-
ment of 22 A˚ length in PPII conformation (Douangamath
et al., 2002).
Both Z1FLAG and Z1PxxP variants were undemanding to
produce in E.coli and yielded 30–40 mg of pure protein per 1 l
culture, resembling yields obtained for wild-type Z1. The
size-exclusion chromatograms of variants and wild type were
also similar (Fig. 2a), indicating that the grafted variants retain
the monomeric character of the domain. To estimate the effect
of the modifications on fold stability, the thermal denaturation
of Z1, Z1FLAG and Z1PxxP was monitored using DSF (Fig. 2b).
The melting temperature (Tm) of wild-type Z1 was 72.6+
0.168C, in good agreement with CD data previously reported
(Tm ¼ 69.4+0.18C) (Politou et al., 1995). Variants Z1FLAG
and Z1PxxP yielded Tm values of 60.48+0.088C and 58.94+
0.748C, respectively. While their DTm108C indicated that the
alteration of the CD loop was destabilizing, the overall thermal
stability of the variants still resembled (and even surpassed)
that of other naturally occurring Ig domains in titin (Politou
et al., 1995;Mayans et al., 2001).
The reduction in stability led us to investigate a possible
perturbation of the secondary structure of the fold. For this,
we studied the FTIR spectra of wild type and variants
(Fig. 2c). The amide I0 band (prime indicates fully deuterated
amide groups) from all samples presented a low maximal
frequency (1633 cm21 for Z1 and Z1PxxP, and 1635 cm21 for
Z1FLAG), characteristic of b-rich proteins (Barth, 2007).
Side-chain contributions from Gln and Asn residues (1635–
1650 cm21), Arg (1608 and 1586 cm21) or Tyr and Trp
(1615 cm21) (Barth, 2007) should be negligible due to the
low (and nearly identical) content of these amino acids in
the samples (Gln/Asn 7%; Arg 3–4%; Tyr/Trp, 3%).
Thus, the FTIR spectra could be comparatively interpreted in
terms of secondary structure content. The spectra of Z1 and
Z1PxxP were virtually identical, indicating a highly similar
secondary structure. The Z1FLAG spectrum showed a small
difference compared with that of Z1 and Z1PxxP in that the
maximum of its amide I’ band was shifted towards a slightly
higher value. An influence from changes in side-chain
absorbance can be excluded; as these would have the
opposite effect (the replacement of Gln by Tyr would shift
the band to lower frequencies). The shift to higher values is
likely to derive from a slight loosening of the b-strands in
Z1FLAG compared with Z1 and Z1PxxP. Still, the shift is very
small and the secondary structure of Z1FLAG can be deduced
to be closely similar to that of Z1.
Fig. 1. The Z1 domain. (a) Crystal structure of Z1. Secondary structure
elements are labelled. The protruding CD loop undergoing grafting is shown
in dark grey; (b) Sequence spanning the CD loop in Z1 and the engineered
variants Z1FLAG and Z1PxxP (inserts are in grey); (c) Sequence conservation
derived from the alignment of all Ig domains from titin mapped onto the 3D
structure of Z1. A white-to-black gradient is used to indicate low (,10%
seq. id; white) to high (.90% seq. id; black) conservation levels. (This
figure is provided in color as Supplementary Fig. S4.)
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Taken together, data from size-exclusion chromatography,
DSF and FTIR suggest that the modification of the CD loop
has been well tolerated by Z1 and that the contribution of I46
to fold stability is dispensable. The diverse nature of the
grafted sequences shows that the effect is general and that the
loop can accommodate contrasting amino acid compositions
as well as long insertions beyond the native length of the loop.
Localization of structural alterations in Z1FLAG by NMR
The small structural changes in Z1FLAG relative to Z1 and
Z1PxxP prompted a detailed analysis of this variant by NMR.
As reference, the [1H,15N]-HSQC spectrum of Z1 was
recorded (Fig. 3a and Supplementary Fig. S2). This con-
tained well-dispersed peaks of uniform line width as
expected for a small rigid globular protein. The chemical
shifts of the isolated Z1 were similar to those previously
reported for Z1 within the Ig–Ig pair Z1–Z2 (Edlich and
Muhle-Goll, 2003). The [1H,15N]-HSQC spectrum of Z1FLAG
(Fig. 3b and Supplementary Fig. S2) showed an overall
chemical shift dispersion similar to that of Z1, indicating
that it has an equivalent globular fold. However, a few peaks
in this spectrum had broadened noticeably. Comparative
spectra recorded at significantly lower protein concentration
(0.01 mM instead of 1 mM otherwise employed in this work)
and increased ionic strength (100 mM NaCl instead of
20 mM used otherwise) demonstrated no change in resonance
broadening or significant variation in chemical shifts
(Supplementary Fig. S3). This suggested that resonance
broadening is caused by an internal dynamic process loca-
lized to a small region of the fold, and not by intermolecular
association. In the latter, a concentration dependence of
chemical shifts of the broadened resonances would be
expected, as well as a reduction of the broadening at low
concentrations.
Most of the Z1FLAG signals could be assigned using
triple-resonance experiments, except for sequences E36-F40
and V54-S58 (b-strands C and D, respectively) that flank
the modified loop (Fig. 3c). We concluded that the missing
signals corresponded to the severely broadened resonances
that remained unassigned. This identified b-strands C and D
as the main regions undergoing conformational exchange
that is intermediate on the NMR time scale. This suggested
a loosening of those strands, in agreement with FTIR
data. The strands must remain associated to their respective
b-sheets as their detachment would have resulted in a
sharpening (not a broadening) of their signals. Their detach-
ment would have also caused more significant changes in
the FTIR-amide I’ band. The loosening of b-strands C and
D in Z1FLAG might be primarily caused by the removal
of the hydrophobic group I46, which is wedged between
the strands and possibly stabilizes their mutual packing
(Fig. 1c).
Next, the degree of broadening of the assigned resonances
in the Z1FLAG spectrum was estimated from the ratio
IZ1FLAG/IZ1 calculated for each cross peak. This ratio was
normalized to give an average value of 1 for non-broadened
resonances. An increase in IZ1FLAG/IZ1 ratio indicated a nar-
rowing of the line-width of a given Z1FLAG signal relative to
that of Z1, while a decrease signified resonance broadening.
The ratio was close to 1 for the majority of the assigned
cross peaks, suggesting that the alteration of the CD loop had
little effect on most residues. Only a small number of reso-
nances showed significant broadening (IZ1FLAG/IZ1, 0.4).
Mapping the corresponding residues onto the Z1 structure
(Fig. 3c) revealed that these were located next to b-strands C
and D, or connected to them through a network of contacts,
indicating that the perturbation of the scaffold by the loop
modification was restricted to the immediate vicinity of the
latter. In contrast, the introduced sequence showed increased
mobility (IZ1FLAG/IZ1 . 1). In Z1, the intensities of the CD
loop resonances were similar to those in the b-strands, sug-
gesting that the loop is immobilized and in close contact
with the rest of the structure (as confirmed by the
Fig. 2. Z1 fold stability. (a) Size-exclusion chromatograms in 50 mM
Tris-HCl pH 7.4, 100 mM NaCl at sample concentrations of 5 mg/ml.
Exclusion volumes were: 76.14 ml for Z1, 74.97 ml for Z1FLAG and
75.45 ml for Z1PxxP; (b) DSF curves showing the increase in the unfolded
protein fraction as a function of temperature; (c) FTIR spectra of the amide
I’ region (the spectra of Z1PxxP and Z1FLAG were scaled to that of Z1 to
yield a same maximum absorbance). Throughout, a solid black line indicates
Z1, dashed line is Z1FLAG and solid grey line is Z1PxxP.
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crystallographic model; Marino et al., 2006; Zou et al.,
2006). In the grafted loop, a decrease in line width signified
an increase in internal dynamics, indicating that it had now
disengaged from the b-structure and, in agreement with
expectations, formed a structurally disordered loop.
The structural effect of the modification was further evalu-
ated by comparison of 13CO, 13Ca and
13Cb chemical shifts
that report on the backbone dihedral angles. These values
were very similar for most residues in Z1 and Z1FLAG, with
the average difference ,0.3 ppm (Fig. 4a). Significant differ-
ences (.0.5 ppm) were few and vicinal to b-strands C and
D (Fig. 4b). To translate the differences in chemical shifts
into differences in structure, we predicted the values of the
backbone dihedral angles for residues in Z1 and Z1FLAG
from their respective chemical shifts and calculated the
difference. For most residues, the values were within 108 of
each other, with even the largest difference below 208
(Fig. 4c and d), in agreement with the small differences in
chemical shifts. Notably, the predicted differences in dihedral
angles were significantly smaller than the precision of the
prediction, which was 20–308 for most residues. This preci-
sion is typical of DANGLE (Cheung et al., 2010), which
estimates the variation of dihedral angles from a fragment
database. However, when comparing proteins with localized
mutations and small changes in chemical shift values, such
precision estimation is misleading, as it suggests relatively
large variation in dihedral angles even if all the chemical
shifts are identical. Thus, the direct comparison of the pre-
dicted values as a measure of dihedral angle variation is
more appropriate for the analysis of the effect of the muta-
tion in this study. For the grafted FLAG sequence, the angle
prediction was unreliable, correlating with a lack of defined
conformation and noticeable mobility. The small predicted
variations in backbone dihedral angles demonstrated that the
secondary structure and, thus, the fold of Z1 was largely
unaffected by the CD loop modification. In summary, in
agreement with deductions from FTIR data, NMR showed
that the effect of grafting the FLAG tag in the CD loop was
limited to a certain exchange in b-strands C and D, but that
this did not disrupt the fold.
Functionality of exogenous peptides in Z1
The functionality of the peptides displayed in the CD loop
was tested using pull-down assays. For Z1FLAG, the purified
sample was incubated with anti-FLAG M2 agarose beads
and eluted with free FLAG peptide. The variant clearly inter-
acted with the resin, while wild-type Z1 did not reveal any
detectable retention (Fig. 5a). This prompted us to study
further the efficiency of the binding with the anti-FLAG anti-
body M2 in solution using isothermal titration calorimetry
(ITC) (Fig. 5b). This yielded an estimated Kd of 1.47+
21.5 mM and the expected stoichiometry of 1 : 1, showing
that the bioreactivity of the inserted peptide is in a scale
comparable to that of general biological processes.
In contrast, a pull-down assay that used Z1PxxP versus the
SH3 domain of Pexp13 failed to reveal binding.
Size-exclusion chromatography further showed that the
samples did no co-emigrate but segregated as individual
species, confirming the absence of significant interaction.
This result might be due to the substantial length of the
recognition sequence and the conformational requirements of
the binding in this case (Douangamath et al., 2002). In Z1,
the end points of the CD loop are 20 A˚ apart, so that the
inserted 14 aa peptide might be forced into a bended struc-
ture that might preclude recognition. In addition, the high
content of hydrophobic residues in the peptide could have
caused a certain collapse of the engineered loop onto itself
or onto the b-sandwich, so that the sequence might not be
available for interaction. The rational introduction of such
complex binders into protein scaffolds is difficult and this
goal might be better achieved through display/selection
technologies.
In conclusion, intracellular Ig domains are robust protein
folds that are undemanding to produce recombinantly in
bacterial cultures. The titin myofilament is a rich source of
such Ig frames and a number of domains (see above) are
Fig. 3. Structural and dynamical comparison of Z1 and Z1FLAG. [1H,15N]-HSQC spectra of (a) Z1 and (b) Z1FLAG. Resonance assignments are shown in
Supplementary Fig. S2. Low-intensity, broad, unassigned cross peaks in the Z1FLAG spectrum are marked with arrows; (c) Resonance broadening in the
Z1FLAG [1H,15N]-HSQC spectrum mapped onto the structure of Z1 (relative intensities calculated as IZ1
FLAG/IZ1). The modified CD loop is in black. Residues
unassigned due to severe exchange broadening are confined to b-strands C and D and shown in dark grey. A decrease in relative intensity by a factor .2.5
respect to the average value is observed only for sparse groups and is indicated in medium grey. (This figure is provided in color as Supplementary Fig. S5.)
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now well-characterized that constitute a valuable diversity
for experimentation. Intracellular I-Ig contain regions of
natural variability and, in particular, the CD loop tolerates
substantial modifications and is suitable for the engineering
of recognition elements into the fold. It is possible that the
adjacent, naturally variable EF loop might also tolerate
diversification and that, together, both loops might permit
developing complex 3D binding interfaces for molecular
partners. Interestingly, the CD loop is remote from Ig–Ig
interfaces in the natural poly-domain arrays of titin as well
as from the self-assembling interface of a synthetic titin-
based polymer recently reported (Bruning et al., 2010).
Fig. 4. Dihedral angle analysis from 13C chemical values. (a) Average difference between the values of 13CO, 13Ca and
13Cb chemical shifts of Z1 and
Z1FLAG; (b) Mapping of chemical shift differences onto the structure of Z1. The modified CD loop is in black. Residues unassigned in b-strands C and D due
to broadening are in dark grey and average chemical shift differences .0.5 ppm are in medium grey; (c and d) differences in w and c backbone dihedral
angles (in degrees) predicted from the chemical shifts of Z1 and Z1FLAG. (This figure is provided in color as Supplementary Fig. S6.)
Fig. 5. Molecular binding properties of Z1FLAG. (a) Pull-down assay using anti-FLAG M2 affinity gel. The SDS-PAGE shows molecular weight markers (M),
incubated samples (L), unbound (F: flow-through, W1-4: washes) and bound fraction (E: elution); (b) ITC data on the interaction to anti-FLAG antibody.
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Thus, it is tantalizing to envision the intracellular I-Ig fold as
a promising protein scaffold for the development of protein
polymers with controlled functions that might allow to
bridge traditional Ig-based technologies and higher order
assemblies in biotechnology.
Supplementary data
Supplementary data are available at PEDS online.
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